Doses dans les organes à risque en radiothérapie conformationnelle et en radiothérapie en conditions stéréotaxiques : os et moelle osseuse

Emami, 1991, Tolerance of normal tissue to therapeutic irradiation, Int J Radiat Oncol Biol Phys, 21, 109, 10.1016/0360-3016(91)90171-Y Pasquier, 2016, Radiothérapie stéréotaxique des métastases osseuses vertébrales, Cancer Radiother, 20, 500, 10.1016/j.canrad.2016.07.073 Green, 2014, Consequences of irradiation on bone and marrow phenotypes, and its relation to disruption of hematopoietic precursors, Bone, 63, 87, 10.1016/j.bone.2014.02.018 Hindorf, 2010, EANM Dosimetry Committee guidelines for bone marrow and whole-body dosimetry, Eur J Nucl Med Mol Imaging, 37, 1238, 10.1007/s00259-010-1422-4 Drouet, 2010, Dose de tolérance à l’irradiation des tissus sains : la moelle osseuse, Cancer Radiother, 14, 392, 10.1016/j.canrad.2010.04.006 Nyaruba, 1998, Bone fragility induced by X-ray irradiation in relation to cortical bone-mineral content, Acta Radiol Stockh Swed, 39, 43 Mutyala, 2008, Dose constraint recommendations and a predictive nomogram of incidence of hematological toxicity for cervix cancer patients treated with concurrent cisplatin and intensity modulated radiation therapy (IMRT), Int J Radiat Oncol, 72, S359, 10.1016/j.ijrobp.2008.06.1189 Brixey, 2002, Impact of intensity-modulated radiotherapy on acute hematologic toxicity in women with gynecologic malignancies, Int J Radiat Oncol, 54, 1388, 10.1016/S0360-3016(02)03801-4 Noël, 2016, Délinéation des organes à risque et contraintes dosimétriques, Cancer Radiother, 20, S36, 10.1016/j.canrad.2016.07.032 Mahantshetty, 2012, Comparison of 2 contouring methods of bone marrow on CT and correlation with hematological toxicities in non-bone marrow-sparing pelvic intensity-modulated radiotherapy with concurrent cisplatin for cervical cancer, Int J Gynecol Cancer, 22, 1427, 10.1097/IGC.0b013e3182664b46 Nugent, 2010, Chemoradiation in locally advanced cervical carcinoma: an analysis of cisplatin dosing and other clinical prognostic factors, Gynecol Oncol, 116, 438, 10.1016/j.ygyno.2009.09.045 Mell, 2008, Dosimetric comparison of bone marrow-sparing intensity-modulated radiotherapy versus conventional techniques for treatment of cervical cancer, Int J Radiat Oncol, 71, 1504, 10.1016/j.ijrobp.2008.04.046 Chang, 2016, Correlations between radiation dose in bone marrow and hematological toxicity in patients with cervical cancer: a comparison of 3DCRT, IMRT, and RapidARC, Int J Gynecol Cancer, 26, 770, 10.1097/IGC.0000000000000660 Erpolat, 2014, Comparison of hematologic toxicity between 3DCRT and IMRT planning in cervical cancer patients after concurrent chemoradiotherapy: a national multi-center study, Eur J Gynaecol Oncol, 35, 62 Noticewala, 2017, Longitudinal changes in active bone marrow for cervical cancer patients treated with concurrent chemoradiation therapy, Int J Radiat Oncol, 97, 797, 10.1016/j.ijrobp.2016.11.033 Rose, 2012, Correlation between radiation dose to (18F)-FDG-PET defined active bone marrow subregions and acute hematologic toxicity in cervical cancer patients treated with chemoradiotherapy, Int J Radiat Oncol, 83, 1185, 10.1016/j.ijrobp.2011.09.048 Mell, 2017, Bone marrow-sparing intensity modulated radiation therapy with concurrent cisplatin for stage IB-IVA cervical cancer: an international multicenter phase II clinical trial (INTERTECC-2), Int J Radiat Oncol, 97, 536, 10.1016/j.ijrobp.2016.11.027 Liang, 2013, Prospective study of functional bone marrow-sparing intensity modulated radiation therapy with concurrent chemotherapy for pelvic malignancies, Int J Radiat Oncol, 85, 406, 10.1016/j.ijrobp.2012.04.044 Schwartz, 2012, Bone Marrow dosimetry using (124I)-PET, J Nucl Med, 53, 615, 10.2967/jnumed.111.096453 Dinges, 2015, Bone marrow sparing in intensity modulated proton therapy for cervical cancer: efficacy and robustness under range and setup uncertainties, Radiother Oncol, 115, 373, 10.1016/j.radonc.2015.05.005 Maingon, 2016, Chapitre commun à la prise en charge et à la procédure de préparation des traitements des cancers de la tête et du cou, Cancer Radiother, 20, S96, 10.1016/j.canrad.2016.07.001 RTOG 0529. Protocol information. n.d. https://www.rtog.org/ClinicalTrials/ProtocolTable/StudyDetails.aspx?study=0529. Wang, 2016, Correlation between intensity modulated radiotherapy and bone marrow suppression in breast cancer, Eur Rev Med Pharmacol Sci, 20, 75 Carmona, 2014, Fat composition changes in bone marrow during chemotherapy and radiation therapy, Int J Radiat Oncol, 90, 155, 10.1016/j.ijrobp.2014.05.041 Kunos, 2012, Hematological toxicity after robotic stereotactic body radiosurgery for treatment of metastatic gynecologic malignancies, Int J Radiat Oncol, 84, e35, 10.1016/j.ijrobp.2012.02.027 Uezono, 2013, Pelvic insufficiency fracture after definitive radiotherapy for uterine cervical cancer: retrospective analysis of risk factors, J Radiat Res (Tokyo), 54, 1102, 10.1093/jrr/rrt055 Schmeler, 2010, Pelvic fractures after radiotherapy for cervical cancer: implications for survivors, Cancer, 116, 625, 10.1002/cncr.24811 İğdem, 2010, Insufficiency fractures after pelvic radiotherapy in patients with prostate cancer, Int J Radiat Oncol, 77, 818, 10.1016/j.ijrobp.2009.05.059 Baxter, 2005, Risk of pelvic fractures in older women following pelvic irradiation, JAMA, 294, 2587, 10.1001/jama.294.20.2587 Lundin, 1990, Insufficiency fractures of the sacrum after radiotherapy for gynaecological malignancy, Acta Oncol, 29, 211, 10.3109/02841869009126547 Oh, 2014, Insufficiency fracture after radiation therapy, Radiat Oncol J, 32, 213, 10.3857/roj.2014.32.4.213 Moreno, 1999, Pelvic insufficiency fractures in patients with pelvic irradiation, Int J Radiat Oncol, 44, 61, 10.1016/S0360-3016(98)00534-3 Oh, 2008, Pelvic Insufficiency fracture after pelvic radiotherapy for cervical cancer: analysis of risk factors, Int J Radiat Oncol, 70, 1183, 10.1016/j.ijrobp.2007.08.005 Kim, 2012, Fractures of the sacrum after chemoradiation for rectal carcinoma: incidence, risk factors, and radiographic evaluation, Int J Radiat Oncol, 84, 694, 10.1016/j.ijrobp.2012.01.021 Mehmood, 2014, Insufficiency fractures in patients treated with pelvic radiotherapy and chemotherapy for uterine and cervical cancer: insufficiency fractures following pelvic radiotherapy, Eur J Cancer Care (Engl), 23, 43, 10.1111/ecc.12105 Nama, 2015, Does intensity-modulated radiotherapy reduce the risk of pelvic insufficiency fractures in gynaecological cancers?, J Radiother Pract, 14, 219, 10.1017/S1460396914000430 Ioffe, 2014, Postradiation damage to the pelvic girdle in cervical cancer patients: is intensity-modulated radiation therapy safer than conventional radiation?, Int J Gynecol Cancer, 24, 806, 10.1097/IGC.0000000000000117 Shih, 2013, Pelvic insufficiency fractures in patients with cervical and endometrial cancer treated with postoperative pelvic radiation, Gynecol Oncol, 128, 540, 10.1016/j.ygyno.2012.12.021 Ogino, 2003, Pelvic insufficiency fractures in postmenopausal woman with advanced cervical cancer treated by radiotherapy, Radiother Oncol, 68, 61, 10.1016/S0167-8140(03)00128-2 Dybvik, 2014, Pelvic irradiation does not increase the risk of hip replacement in patients with gynecological cancer: a cohort study based on 8,507 patients, Acta Orthop, 85, 652, 10.3109/17453674.2014.963784 Okoukoni, 2017, Early dose-dependent cortical thinning of the femoral neck in anal cancer patients treated with pelvic radiation therapy, Bone, 94, 84, 10.1016/j.bone.2016.10.021 Pak, 2012, Dose–effect relationships for femoral fractures after multimodality limb-sparing therapy of soft-tissue sarcomas of the proximal lower extremity, Int J Radiat Oncol, 83, 1257, 10.1016/j.ijrobp.2011.09.047 Dickie, 2009, Bone fractures following external beam radiotherapy and limb-preservation surgery for lower extremity soft tissue sarcoma: relationship to irradiated bone length, volume, tumor location and dose, Int J Radiat Oncol, 75, 1119, 10.1016/j.ijrobp.2008.12.006 Bishop, 2016, Treatment-related fractures after combined modality therapy for soft tissue sarcomas of the proximal lower extremity: can the risk be mitigated?, Pract Radiat Oncol, 6, 194, 10.1016/j.prro.2015.09.004 Pointreau, 2016, Radiothérapie conformationnelle avec modulation d’intensité des cancers des voies aérodigestives supérieures. Dose de tolérance des tissus sains : glandes salivaires et mandibule, Cancer Radiother, 20, 445, 10.1016/j.canrad.2016.07.066 Gomez, 2011, Correlation of osteoradionecrosis and dental events with dosimetric parameters in intensity-modulated radiation therapy for head-and-neck cancer, Int J Radiat Oncol, 81, e207, 10.1016/j.ijrobp.2011.02.003 Maingon, 2004, Les contraintes aux organes à risque en radiothérapie par modulation d’intensité des cancers ORL, Cancer Radiother, 8, 234, 10.1016/j.canrad.2004.06.002 Tsai, 2013, Osteoradionecrosis and radiation dose to the mandible in patients with oropharyngeal cancer, Int J Radiat Oncol, 85, 415, 10.1016/j.ijrobp.2012.05.032 Grimm, 2011, Dose tolerance limits and dose–volume histogram evaluation for stereotactic body radiotherapy, J Appl Clin Med Phys, 12, 3368, 10.1120/jacmp.v12i2.3368 Nambu, 2013, Rib fracture after stereotactic radiotherapy for primary lung cancer: prevalence, degree of clinical symptoms, and risk factors, BMC Cancer, 13 Kimsey, 2016, Dose-response model for chest wall tolerance of stereotactic body radiation therapy, Semin Radiat Oncol, 26, 129, 10.1016/j.semradonc.2015.11.003 Miura, 2015, Differences in rates of radiation-induced true and false rib fractures after stereotactic body radiation therapy for stage I primary lung cancer, J Radiat Res (Tokyo), 56, 332, 10.1093/jrr/rru107 Chi, 2016, Chest wall dose assessment in stereotactic ablative radiotherapy delivered with volumetric modulated arc therapy for peripheral lung tumors, Cancer Treat Res Commun, 9, 5, 10.1016/j.ctarc.2016.06.007 Taremi, 2012, Predictors of radiotherapy induced bone injury (RIBI) after stereotactic lung radiotherapy, Radiat Oncol, 7, 159, 10.1186/1748-717X-7-159 Murray, 2016, Lung stereotactic ablative radiotherapy (SABR): dosimetric considerations for chest wall toxicity, Br J Radiol, 89, 20150628, 10.1259/bjr.20150628 Stam, 2017, Dose–effect analysis of radiation induced rib fractures after thoracic SBRT, Radiother Oncol, 10.1016/j.radonc.2017.01.004 Asai, 2012, Radiation-induced rib fractures after hypofractionated stereotactic body radiation therapy: risk factors and dose–volume relationship, Int J Radiat Oncol, 84, 768, 10.1016/j.ijrobp.2012.01.027 Dunlap, 2010, Chest wall volume receiving >30Gy predicts risk of severe pain and/or rib fracture after lung stereotactic body radiotherapy, Int J Radiat Oncol, 76, 796, 10.1016/j.ijrobp.2009.02.027 Abe, 2016, Incidence, risk factors, and dose-volume relationship of radiation-induced rib fracture after carbon ion radiotherapy for lung cancer, Acta Oncol, 55, 163, 10.3109/0284186X.2015.1088169 Rodríguez-Ruiz, 2012, Pathological vertebral fracture after stereotactic body radiation therapy for lung metastases. Case report and literature review, Radiat Oncol, 7, 50, 10.1186/1748-717X-7-50 Sahgal, 2013, Vertebral compression fracture after spine stereotactic body radiotherapy: a multi-institutional analysis with a focus on radiation dose and the spinal instability neoplastic score, J Clin Oncol, 31, 3426, 10.1200/JCO.2013.50.1411 Lutz, 2011, Palliative radiotherapy for bone metastases: an ASTRO evidence-based guideline, Int J Radiat Oncol, 79, 965, 10.1016/j.ijrobp.2010.11.026 Chiang, 2013, Pain flare is a common adverse event in steroid-naïve patients after spine stereotactic body radiation therapy: a prospective clinical trial, Int J Radiat Oncol, 86, 638, 10.1016/j.ijrobp.2013.03.022 Sahgal, 2013, Vertebral compression fracture after stereotactic body radiotherapy for spinal metastases, Lancet Oncol, 14, e310, 10.1016/S1470-2045(13)70101-3 Rose, 2009, Risk of fracture after single fraction image-guided intensity-modulated radiation therapy to spinal metastases, J Clin Oncol, 27, 5075, 10.1200/JCO.2008.19.3508 Cunha, 2012, Vertebral compression fracture (VCF) after spine stereotactic body radiation therapy (SBRT): analysis of predictive factors, Int J Radiat Oncol, 84, e343, 10.1016/j.ijrobp.2012.04.034 Thibault, 2014, Spine stereotactic body radiotherapy for renal cell cancer spinal metastases: analysis of outcomes and risk of vertebral compression fracture: clinical article, J Neurosurg Spine, 21, 711, 10.3171/2014.7.SPINE13895